Title: Sudo H, et al. Oral administration of MA-2029, a novel selective and competitive motilin receptor antagonist, inhibits motilin-induced intestinal contractions and visceral pain in rabbits. Eur J Pharmacol. 2008 Mar 10;581(3):296-305.
5625-40-1
5845-66-9
19361-52-5
21754-25-6
118476-87-2
21754-26-7
186901-17-7 | L-Leucine,L-arginyl-L-arginyl-L-alanyl-L-alanyl-L-a-glutamyl-L-a-glutamyl-L-leucyl-L-a-aspartyl-L-seryl-L-arginyl-L-alanylglycyl-O-phosphono-L-seryl-L-prolyl-L-glutaminyl- | AA01ENNQ | MFCD06798312
1616287-82-1 | PF-06726304 | AA01ENUH | MFCD31563584
2146095-85-2 | SHIN1 | AA01EO1U | MFCD31657406
1472797-69-5 | FLT3-IN-1 | AA01EO54 | MFCD31630735
1190221-43-2 | TM5441 | AA01EOBA | MFCD01818762
910484-28-5 | TTA-Q6 | AA01EOGG | MFCD15528951
1562066-98-1 | Banoxantrone D12 dihydrochloride | AA01EOM7 | MFCD31544354
139023-31-7 | 9α,11α,15S-trihydroxy-16,16-difluoro-prosta-5Z-en-1-oicacid | AA01EOQU
4865-61-6 | erythro-3,4-dimethyl-α-[1-(methylamino)ethyl]-benzylalcohol,monohydrochloride | AA01EP1N
2095432-59-8 | N-methyl-4-(phenylmethoxy)-1-piperidineethanamine,dihydrochloride | AA01EPB2